Neuroscience Institute of Schizophrenia and Allied Disorders (NISAD): 10 years of Australia's first virtual research institute

References

• Loughland CM, Carr VJ, Lewin TJ. The NISAD Schizophrenia Research Register: why do we need a database of schizophrenia volunteers?. Aust N Z J Psychiatry 2001; 35: 660–667
   PubMed Web of Science ®Google Scholar
• Loughland CM, Carr VJ, Lewin TJ, Barnard RE, Chapman JL, Walton JM. Potential sampling and recruitment source impacts in schizophrenia research. Psychiatry Res 2004; 125: 117–127
   PubMed Web of Science ®Google Scholar
• Carr VJ, Lewin TJ, Barnard RE, et al. Comparisons between schizophrenia patients recruited from Australian general practices and public mental health services. Acta Psychiatr Scand 2002; 105: 346–355
   PubMedGoogle Scholar
• Loughland, C, Lewin, T, Carr, V, Sheedy, J, Harris, A. RBANS neuropsychological profiles within schizophrenia samples recruited from non-clinical settings. Schizophr Res ( in press).
   Google Scholar
• Garrick T, North A, Glaw X, Harper CG. The diagnosis is critical for psychiatric brain banks: an inter-rater reliability study. Aust N Z J Psychiatry 2006; 40: 606–607
   PubMedGoogle Scholar
• Sarris M, Garrick TM, Sheedy D, Harper CG. Banking for the future: an Australian experience in Brain Banking. Pathology 2002; 34: 225–229
   PubMed Web of Science ®Google Scholar
• Boyes M, Ward P. Brain donation for schizophrenia research: gift, consent and meaning. J Med Ethics 2003; 29: 165–168
   PubMed Web of Science ®Google Scholar
• Azizi L, Garrick TM, Merrick J, Harper CG. Brain donation for research: strong support in Australia. J Clin Neurosci 2006; 13: 449–452
   PubMed Web of Science ®Google Scholar
• Russell SG, Loughland CM, Tooney PA, Scott RJ, Lewin TJ, Carr V. The Hunter DNA Bank for Schizophrenia and Allied Disorders: a unique Australian resource facilitating genetic research into mental illness. Aust N Z J Psychiatry 2005; 39: A68
   Google Scholar
• Thompson PM, Vidal C, Giedd JN, et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci USA 2001; 98: 11650–11655
   PubMed Web of Science ®Google Scholar
• Schall U, Johnston P, Lagopoulos J, et al. Functional brain maps of Tower of London performance: a positron emission tomography and functional magnetic resonance imaging study. Neuroimage 2003; 20: 1154–1161
   PubMed Web of Science ®Google Scholar
• Ward PB, Schall UA, Lagopoulos J, Bender S, Little CL. Functional brain imaging of increasing task difficulty in the Tower of London in patients with schizophrenia and healthy volunteers: an fMRI study. Neuroimage 2001; 13: 1114
   Google Scholar
• Rasser PE, Johnston P, Lagopoulos J, et al. Functional MRI BOLD response to Tower of London performance of first-episode schizophrenia patients using cortical pattern matching. Neuroimage 2005; 26: 941–951
   PubMedGoogle Scholar
• Schall U, Johnston P, Todd J, Ward PB, Michie PT. Functional neuroanatomy of auditory mismatch processing: an event-related fMRI study of duration-deviant oddballs. Neuroimage 2003; 20: 729–736
   Google Scholar
• Schall U, Johnston P, Todd J, Ward PB, Michie P. Functional brain imaging of auditory mismatch processing in schizophrenia. Schizophr Bull 2005; 31: 433
   Google Scholar
• Michie PT, Todd J, Schall U, Karayanidis F. Duration of illness and mismatch negativity in schizophrenia. World J Biol Psychiatry 2005; 6: 52
   Google Scholar
• Matthews NL, Todd J, Cooper G, Finnigan S, Catts S, Michie PT. Temporal processing in schizophrenia: evidence for impairment across a range of time scales. Aust N Z J Psychiatry 2006; 40: A116
   Google Scholar
• Richards AL, Todd J, Michie PT. Insensitivity to temporal context in schizophrenia. Aust N Z J Psychiatry 2006; 40: A116
   Google Scholar
• Nicholson R, Karayanidis F, Poboka D, Heathcote A, Michie P. Electrophysiological components associated with anticipatory task-switching processes. Psychophysiology 2005; 42: 540–554
   PubMed Web of Science ®Google Scholar
• Nicholson R, Karayanidis F, Bumak E, Poboka D, Michie P. ERPs dissociate the effects of switching task-sets and task-cues. Brain Res 2006; 1095: 107–123
   Google Scholar
• Karayanidis, F, Nicholson, R, Meem, L, Michie, P, Schall, U. Switching between univalent task-sets in schizophrenia: ERP evidence of an anticipatory task-set reconfiguration deficit. Clin Neurophysiol 2006; 117:2172–2190 ( in press).
   PubMed Web of Science ®Google Scholar
• Clunas NJ, Ward PB. Auditory recovery cycle dysfunction in schizophrenia: a study using event related potentials. Psychiatry Res 2005; 136: 17–25
   Google Scholar
• Clunas NJ, Ward PB. Altered auditory recovery cycle function in schizophrenia and bipolar disorder: an ERP study. Schizophr Bull 2005; 31: 451
   Google Scholar
• Loughland CM, Williams LM, Gordon E. Visual scanpaths to positive and negative facial emotions in an outpatient schizophrenia sample. Schizophr Res 2002; 55: 159–170
   PubMed Web of Science ®Google Scholar
• Loughland CM, Williams LM, Harris AW. Visual scanpath dysfunction in first-degree relatives of schizophrenia probands: evidence for a vulnerability marker. Schizophr Res 2004; 67: 11–21
   PubMed Web of Science ®Google Scholar
• Loughland CM, Williams LM, Gordon E. Schizophrenia and affective psychosis show different visual scanning behaviour for faces: a trait verses state-based distinction. Biol Psychiatry 2002; 52: 338–348
   PubMed Web of Science ®Google Scholar
• Williams LM, Loughland CM, Green MJ, Harris AWF, Gordon E. Emotion perception in schizophrenia: an eye movement study comparing the effectiveness of risperidone vs. haloperidol. Psychiatry Res 2003; 120: 13–27
   PubMed Web of Science ®Google Scholar
• Green MJ, Williams LM, Davidson DJ. Visual scanpaths to threat-related faces in deluded schizophrenia. Psychiatry Res 2003; 119: 271–285
   PubMed Web of Science ®Google Scholar
• Green MJ, Waldron JH, Coltheart M. Eye movements reflect aberrant processing of social context in schizophrenia. Schizophr Bull 2005; 31: 470
   Google Scholar
• Johnston PJ, Katsikitis M, Carr VJ. A generalised deficit can account for problems in facial emotion recognition in schizophrenia. Biol Psychol 2001; 58: 203–227
   PubMed Web of Science ®Google Scholar
• Johnston PJ, McCabe K, Schall U. Differential susceptibility to performance degredation across categories of facial emotion: a model confirmation. Biol Psychol 2003; 63: 45–58
   Google Scholar
• Johnston PJ, Stojanov W, Devir H, Schall U. Functional MRI of facial emotion recognition deficits in schizophrenia and their electrophysiological correlates. Eur J Neurosci 2005; 22: 1221–1232
   PubMed Web of Science ®Google Scholar
• Johnston PJ, Karayanidis F, Devir H. Facial emotion processing in schizophrenia: no evidence for a negative emotion specific deficit using a differential deficit design. Psychiatry Res 2006; 143: 51–61
   PubMed Web of Science ®Google Scholar
• Lagopoulos J, Gordon E, Ward P. Differential BOLD responses to auditory target stimuli associated with a skin conductance response. Acta Neuropsychiatr 2006; 18: 105–114
   Google Scholar
• Williams LM, Brammer MJ, Skerrett D, et al. The neural correlates of orienting: an integration of fMRI and skin conductance orienting. Neuroreport 2000; 11: 3011–3015
   PubMed Web of Science ®Google Scholar
• Williams LM, Phillips ML, Brammer MJ, et al. Arousal dissociates amygdala and hippocampal fear responses: evidence from simultaneous fMRI and skin conductance recording. Neuroimage 2001; 14: 1070–1079
   PubMed Web of Science ®Google Scholar
• Liddell BJ, Brown KJ, Kemp AH, et al. A direct brainstem-amygdala-cortical ‘alarm’ system for subliminal signals of fear. Neuroimage 2005; 24: 235–243
   PubMed Web of Science ®Google Scholar
• Williams LM, Brown KJ, Das P, et al. The dynamics of cortico-amygdala and autonomic activity over the experimental time course of fear perception. Cognitive Brain Res 2004; 21: 114–123
   PubMedGoogle Scholar
• Williams LM, Das P, Liddell B, et al. BOLD, sweat and fears: fMRI and skin conductance distinguish facial fear signals. Neuroreport 2005; 16: 49–52
   Google Scholar
• Williams LM, Das P, Harris AWF, et al. Dysregulation of arousal and amygdala–prefrontal systems in paranoid schizophrenia. Am J Psychiatry 2004; 161: 480–489
   PubMed Web of Science ®Google Scholar
• Das P, Kemp AH, Liddell BJ, et al. Pathways to fear perception: modulation of amygdala activity by thalamo-cortical systems. Neuroimage 2005; 26: 141–148
   PubMed Web of Science ®Google Scholar
• Williams LM, Das P, Flynn G, Harris AWF. ‘Missing links’: loss of functional connectivity in the emotional brain systems in schizophrenia. Aust N Z J Psychiatry 2005; 39: A22
   Google Scholar
• Malhi GS, Lagopoulos J, Sachdev P, Mitchell PB, Ivanovski B, Parker GB. Cognitive generation of affect in hypomania: an fMRI study. Bipolar Disord 2004; 6: 271–285
   PubMed Web of Science ®Google Scholar
• Malhi GS, Lagopoulos J, Ward PB, et al. FMRI of cognitive generation of affect in bipolar depression. Eur J Neurosci 2004; 19: 741–754
   PubMed Web of Science ®Google Scholar
• Langdon R, Corner T, McLaren J, Ward PB, Coltheart M. Externalizing and personalizing biases in persecutory delusions: the relationship with poor insight and theory of mind. Behav Res Ther 2006; 44: 699–713
   PubMed Web of Science ®Google Scholar
• Langdon R, Coltheart M, Ward PB. Empathetic perspective-taking is impaired in schizophrenia: evidence from a study of emotion attribution and theory of mind. Cognitive Neuropsychiatry 2006; 11: 133–155
   PubMedGoogle Scholar
• Langdon R, Corner T, McLaren J, Coltheart M, Ward PB. Attentional orienting triggered by gaze in schizophrenia. Neuropsychologia 2006; 44: 417–429
   PubMed Web of Science ®Google Scholar
• McKay R, Langdon R, Coltheart M. The persecutory ideation questionnaire. J Nerv Ment Dis 2006; 194: 628–631
   PubMed Web of Science ®Google Scholar
• McKay R, Langdon R, Coltheart M. Paranoia, persecutory delusions and attributional biases. Psychiatry Res 2005; 136: 233–245
   PubMed Web of Science ®Google Scholar
• McKay R, Langdon R, Coltheart M. Need for closure, jumping to conclusions, and decisiveness in delusion-prone individuals. J Nerv Ment Dis 2006; 194: 422–426
   PubMed Web of Science ®Google Scholar
• McKay, R, Langdon, R, Coltheart, M. The defensive function of persecutory delusions: an investigation using the implicit association test. Cognit Neuropsychiatry ( in press).
   Google Scholar
• Tooney PA, Au GG, Chahl LA. Localisation of tachykinin NK1 and NK3 receptors in the human prefrontal and visual cortex. Neurosci Lett 2000; 283: 185–188
   PubMed Web of Science ®Google Scholar
• Weidenhofer J, Yip J, Zavitsanou K, Huang XF, Chahl L, Tooney P. Immunohistochemical localisation of the NK1 receptor in the human amygdala: preliminary investigation in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 1313–1321
   Google Scholar
• Tooney PA, Crawter VC, Chahl LA. Increased expression of tachykinin NK1 receptors in the prefrontal cortex in schizophrenia. Biol Psychiatry 2001; 49: 523–527
   PubMedGoogle Scholar
• Tooney PA, Anderson WB, Lynch-Frame A, Chahl LA. The effects of haloperidol treatment on the distribution of NK1 receptor immunoreactive neurons in the guinea pig brain. Neurosci Lett 2005; 383: 155–159
   Google Scholar
• Dixon G, Dissanaike S, Harper CG. Parvalbumin-immunoreactive neurons in the human anteroventral thalamic nucleus. Neuroreport 2000; 11: 96–100
   Google Scholar
• Dixon G, Harper CG. Quantitative analysis of glutamic acid decarboxylase-immunoreactive neurons in the anterior thalamus of the human brain. Brain Res 2001; 923: 39–44
   Google Scholar
• Dixon G, Harper CG. No evidence for selective GABAergic interneuron deficits in the anterior thalamic complex of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 1045–1051
   Google Scholar
• Wheeler DG, Dixon G, Harper CG. No differences in calcium-binding protein immunoreactivity in the posterior cingulate and visual cortex: schizophrenia and normal controls. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 630–639
   Google Scholar
• Dixon G, Garrick T, Whiteman I, Sarris M, Sithamparanathan S, Harper CG. Characterisation of GABAergic neurons within the human medial mamillary nucleus. Neuroscience 2004; 127: 365–372
   Google Scholar
• Tooney PA, Chahl LA. Neurons expressing calcium-binding proteins in the prefrontal cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 273–278
   PubMed Web of Science ®Google Scholar
• Zavitsanou K, Ward PB, Huang XF. Selective alterations of iontropic glutamate receptors in anterior cingulate cortex in schizophrenia. Neuropsychopharmacology 2002; 27: 826–833
   PubMedGoogle Scholar
• Newell KA, Zavitsanou K, Huang XF. Ionotropic glutamate receptor binding in the posterior cingulate cortex in schizophrenia patients. Neuroreport 2005; 16: 1363–1367
   PubMedGoogle Scholar
• Zavitsanou K, Garrick T, Huang XF. Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 355–360
   PubMed Web of Science ®Google Scholar
• Newell KA, Deng C, Huang XF. Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. Exp Brain Res 2006; 172: 556–560
   PubMed Web of Science ®Google Scholar
• Zavitsanou K, Huang XF. Decreased [3H] spiperone binding in the anterior cingulate cortex of schizophrenia patients: an autoradiographic study. Neuroscience 2002; 109: 709–716
   Google Scholar
• Newell, KA, Zavitsanou, K, Jew, SK, Huang, XF. Alterations of muscarinic and GABA receptors in the posterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry ( in press).
   Google Scholar
• Zavitsanou K, Katsifis A, Mattner F, Huang XF. Investigation of M1/M4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder and major depression disorder. Neuropsychopharmacology 2004; 29: 619–625
   PubMed Web of Science ®Google Scholar
• Zavitsanou K, Katsifis A, Yu Y, Huang XF. M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders. Brain Res Bull 2005; 65: 397–403
   PubMedGoogle Scholar
• Zavitsanou K. M1 receptor agonism, a possible treatment for cognitive deficits in schizophrenia. Neuropsychopharmacology 2004; 29: 1585–1586
   Google Scholar
• Deng C, Huang XF. Decreased density of muscarinic receptors in the superior temporal gyrus in schizophrenia. J Neurosci Res 2005; 81: 883–890
   PubMedGoogle Scholar
• Deng C, Huang XF. Increased density of GABA-A receptors in the superior temporal gyrus in schizophrenia. Exp Brain Res 2006; 168: 587–590
   Google Scholar
• Bowden NA, Weidenhofer J, Scott RJ, et al. Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia. Schizophr Res 2006; 82: 175–183
   PubMed Web of Science ®Google Scholar
• Weidenhofer J, Bowden NA, Scott RJ, Tooney PA. Altered gene expression in the amygdala in schizophrenia: upregulation of genes located in the cytomatrix active zone. Mol Cell Neurosci 2006; 31: 243–250
   Google Scholar
• Chetcuti A, Adams LJ, Mitchell PB, Schofield PR. Altered gene expression in mice treated with the mood stabilizer sodium valproate. Int J Neuropsychopharmacol 2006; 9: 267–276
   PubMed Web of Science ®Google Scholar
• Duncan CE, Chetcuti A, Schofield PR. Identification of genes associated with schizophrenia using an animal model of antipsychotic drug action. Am J Med Genet Neuropsychiatr Genet 2005; 138B: 121
   Google Scholar
• Blair IP, Chetcuti AF, Badenhop RF, et al. Positional cloning, association analysis, and expression studies provide convergent evidence that the cadherin gene FAT contains a bipolar disorder susceptibility allele. Mol Psychiatry 2006; 11: 372–383
   PubMed Web of Science ®Google Scholar
• Clark D, Dedova I, Cordwell S, Matsumoto I. A proteome analysis of the anterior cingulate cortex grey matter in schizophrenia. Mol Psychiatry 2006; 11: 459–470
   PubMedGoogle Scholar
• Iwazaki T, McGregor I, Matsumoto I. Protein expression profile in the striatum of acute methamphetamine-treated rats. Brain Res 2006; 1097: 19–25
   PubMed Web of Science ®Google Scholar
• Karl T, Duffy L, Schofield P. Nrg1 knockout mice: an animal model for schizophrenia?. Aust N Z J Psychiatry 2005; 39: A19
   Google Scholar
• Newson P, Lynch-Frame A, Roach R, Bennett S, Carr V, Chahl LA. Intrinsic sensory deprivation induced by neonatal capsaicin treatment induces changes in rat brain and behaviour of possible relevance to schizophrenia. Br J Pharmacol 2005; 146: 408–418
   Google Scholar
• Schleimer SB, Johnston GAR, Henderson JM. Novel oral drug administration in an animal model of neuroleptic therapy. J Neurosci Methods 2005; 146: 159–164
   Google Scholar
• Karl T, Duffy L, O'Brien E, Matsumoto I, Dedova I. Behavioural effects of chronic haloperidol and risperidone treatment in rats. Behav Brain Res 2006; 171: 286–294
   Google Scholar
• O'Brien, E, Dedova, I, Duffy, L, Karl, T, Matsumoto, I. Effects of chronic risperidone treatment on the striatal protein profiles in rats. Brain Res 2006; 1113:24–32.
   PubMed Web of Science ®Google Scholar
• Huang XF, Deng C, Zavitsanou K. Neuropeptide Y gene expression following olanzapine, clozapine and haloperidol administration in rats. Neuropeptides 2006; 40: 213–219
   Google Scholar
• Huang XF, Han M, Huang X, Zavitsanou K, Deng C. Olanzapine differentially affects 5-HT2A and 5-HT2C receptor mRNA expression in the rat brain. Behav Brain Res 2006; 171: 355–362
   PubMedGoogle Scholar
• du Bois TM, Bell W, Deng C, Huang XF. A high n-6 polyunsaturated fatty acid diet reduces muscarinic M2/M4 receptor binding in the rat brain. J Chem Neuroanat 2005; 29: 282–288
   PubMed Web of Science ®Google Scholar
• du Bois TM, Deng C, Bell W, Huang XF. Dietary fatty acids differentially affect 5–HT2 receptor and transporter binding in the rat brain. Neuroscience 2006; 139: 1397–1403
   PubMed Web of Science ®Google Scholar
• Cohen, M, Johnston, P, Ehlkes, T, et al. An fMRI study of cerebral activation differences between cannabis users and schizophrenia patients during the Tower of London task. Schizophr Res 2006; 81:300.
   Google Scholar
• Monterrubio S, Solowij N, Meyer BJ, Turner N. Fatty acid relationships in former cannabis users with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 280–285
   PubMed Web of Science ®Google Scholar
• Baker, A, Richmond, R, Haile, M, et al. Characteristics of smokers with a psychotic illness and implications for smoking interventions. Psychiatry Res ( in press).
   Google Scholar
• Baker A, Bucci S, Lewin TJ, Richmond R, Carr VJ. Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Res 2005; 134: 241–245
   PubMed Web of Science ®Google Scholar
• Baker, A, Richmond, R, Haile, M, et al. Randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. Am J Psychiatry 2006; 163:1934–1942.
   PubMed Web of Science ®Google Scholar
• Baker A, Bucci S, Lewin TJ, Kay-Lambkin F, Constable PM, Carr VJ. Randomised control trial of cognitive behaviour therapy for substance use disorders among people with a psychotic disorder. Br J Psychiatry 2006; 188: 439–448
   PubMed Web of Science ®Google Scholar
• Russell, TA, Chu, E, Phillips, ML. A pilot study to investigate the effectiveness of emotion recognition remediation in schizophrenia using the Micro-Expression Training Tool. Br J Clin Psychol 2006; 45:579–583.
   PubMed Web of Science ®Google Scholar
• Russell TA, Green M, Phillips ML, Coltheart M. Remediation of poor emotion processing in schizophrenia. Aust N Z J Psychiatry 2005; 39: A41
   Google Scholar
• Andresen R, Oades L, Caputi P. The experience of recovery from schizophrenia: towards an empirically validated stage model. Aust N Z J Psychiatry 2003; 37: 586–594
   PubMed Web of Science ®Google Scholar
• Andresen, R, Caputi, P, Oades, L. Stages of recovery instrument: development of a measure of recovery from serious mental illness. Aust N Z J Psychiatry 2006; 40:972–980.
   PubMed Web of Science ®Google Scholar
• Gorrell J, Moss B, Ward PB, et al. Pathways to care in early psychosis: understanding treatment delay. Schizophr Res 2004; 70: 137
   Google Scholar